1,2-distearoylphosphatidylethanolamine has been researched along with Melanoma in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Hei, Y; Li, Q; Luo, Z; Pan, J; Teng, B; Wei, S; Xiong, C; Zeng, Z; Zhang, S | 1 |
Eggermont, AM; Koning, GA; Li, L; Lindner, LH; Schipper, D; ten Hagen, TL; van Rhoon, GC; Wijnberg, TM | 1 |
2 other study(ies) available for 1,2-distearoylphosphatidylethanolamine and Melanoma
Article | Year |
---|---|
Multifunctional Immunoliposomes Combining Catalase and PD-L1 Antibodies Overcome Tumor Hypoxia and Enhance Immunotherapeutic Effects Against Melanoma.
Topics: Animals; Antibodies, Monoclonal; Antineoplastic Agents, Immunological; B7-H1 Antigen; Catalase; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Female; Immunotherapy; Liposomes; Melanoma; Mice, Inbred C57BL; Phosphatidylethanolamines; Polyethylene Glycols; Tissue Distribution; Tumor Hypoxia; Tumor Microenvironment | 2020 |
Triggered content release from optimized stealth thermosensitive liposomes using mild hyperthermia.
Topics: Animals; Fluoresceins; Humans; Hyperthermia, Induced; Liposomes; Melanoma; Mice; Phosphatidylethanolamines; Polyethylene Glycols; Temperature | 2010 |